Vanguard Group Inc. Has $305.65 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Vanguard Group Inc. lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,900,648 shares of the company’s stock after selling 137,827 shares during the quarter. Vanguard Group Inc. owned 5.84% of Doximity worth $305,654,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. G2 Investment Partners Management LLC acquired a new position in Doximity during the 4th quarter worth approximately $2,386,000. Bayesian Capital Management LP acquired a new position in Doximity during the 4th quarter worth approximately $3,390,000. Pinebridge Investments L.P. acquired a new position in Doximity during the 4th quarter worth approximately $2,845,000. Evoke Wealth LLC boosted its position in Doximity by 24.3% during the 4th quarter. Evoke Wealth LLC now owns 12,498 shares of the company’s stock worth $350,000 after acquiring an additional 2,441 shares during the last quarter. Finally, Capstone Investment Advisors LLC acquired a new position in Doximity during the 4th quarter worth approximately $206,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on DOCS shares. Morgan Stanley reiterated an “underweight” rating and set a $25.00 price objective on shares of Doximity in a research note on Tuesday, April 23rd. Needham & Company LLC reiterated a “hold” rating on shares of Doximity in a research note on Friday, May 17th. William Blair reiterated an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. JPMorgan Chase & Co. upgraded Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective on the stock in a research note on Thursday, April 25th. Finally, Evercore ISI upped their price objective on Doximity from $28.00 to $29.00 and gave the stock an “in-line” rating in a research note on Friday, May 17th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $28.73.

Insiders Place Their Bets

In other Doximity news, insider Craig Overpeck sold 1,500 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $23.85, for a total transaction of $35,775.00. Following the transaction, the insider now owns 108,609 shares in the company, valued at approximately $2,590,324.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Anna Bryson sold 30,000 shares of the stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $30.00, for a total transaction of $900,000.00. Following the sale, the chief financial officer now directly owns 288,685 shares of the company’s stock, valued at approximately $8,660,550. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Craig Overpeck sold 1,500 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $23.85, for a total value of $35,775.00. Following the sale, the insider now directly owns 108,609 shares in the company, valued at $2,590,324.65. The disclosure for this sale can be found here. Insiders have sold 46,500 shares of company stock worth $1,371,250 in the last 90 days. Company insiders own 39.40% of the company’s stock.

Doximity Price Performance

DOCS stock opened at $27.97 on Friday. The stock has a market capitalization of $5.19 billion, a price-to-earnings ratio of 38.85, a PEG ratio of 5.20 and a beta of 1.23. The business’s fifty day moving average price is $26.65 and its two-hundred day moving average price is $27.46. Doximity, Inc. has a fifty-two week low of $19.71 and a fifty-two week high of $36.29.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, May 16th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04. The firm had revenue of $118.06 million for the quarter, compared to analysts’ expectations of $116.46 million. Doximity had a return on equity of 17.44% and a net margin of 31.04%. Research analysts expect that Doximity, Inc. will post 0.74 EPS for the current year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.